Tariffs Set to Reshape the Auto Industry
In a move that could significantly alter the global automotive industry, U.S. President Donald Trump has announced plans to impose a 25% tariff on all...
Vobile Revolutionizes Content Creation with AI-Powered DreamMaker Platform
Vobile Group Limited (OTCQX: VOBIF), a global provider of digital content protection and transaction services trading on the NASDAQ, has launched DreamMaker, an innovative platform...
Rupert Resources Secures $51.75 Million in Equity Financing
Rupert Resources Ltd. (TSX:RUP, OTCQX: RUPRF), a gold exploration and development company, has successfully closed a significant equity financing deal. The company raised $51,750,000 through...
Napster’s $207 Million Revival, From Piracy Pioneer to Metaverse Music Platform
The iconic music brand Napster (NYSE: NPSTY), once synonymous with digital piracy, has been acquired by Infinite Reality for $207 million, marking a new chapter...
Trump Signals Potential Flexibility on Upcoming Tariffs
President Donald Trump has indicated that the new tariffs set to be implemented on April 2, 2025, may be less severe than initially anticipated. This...
Aya Gold & Silver Unearths Rich Silver Veins at Zgounder Mine
Aya Gold & Silver Inc. (TSX: AYA; OTCQX: AYASF) has reported impressive high-grade silver drill results from its ongoing exploration program at the Zgounder Silver...
Endo’s Mixed Reality Simulator Reshapes Pharmaceutical Training
In a groundbreaking move, Endo, Inc. (OTCQX: NDOI) has launched the Spatial Computing Injection Simulator, marking a significant leap in medical education technology. This innovative...
Volatus Aerospace Gains Nationwide Nighttime Drone Approval
In a significant development for the drone industry, Volatus Aerospace ((TSXV: FLT, OTCQX: TAKOF, FRA: ABB) has obtained approval from Transport Canada to conduct long-distance,...
Shell Boosts Shareholder Returns, Slashes Spending in Strategic Shift
In a move that has caught the attention of investors and industry analysts alike, Shell (NYSE: SHEL) has announced significant changes to its financial strategy....
Promising Brain Cancer Drug Shows Mixed Results in Late-Stage Trial
A novel brain cancer treatment developed by CNS Pharmaceuticals (NASDAQ: CNSP) has shown mixed results in a late-stage clinical trial. The drug, Berubicin, did not...
